Cargando…
Antiretroviral Therapy Outcomes in HIV-Infected Children after Adjusting Protease Inhibitor Dosing during Tuberculosis Treatment
BACKGROUND: Modification of ritonavir-boosted lopinavir (LPV/r)-based antiretroviral therapy is required for HIV-infected children co-treated for tuberculosis (TB). We aimed to determine virologic and toxicity outcomes among TB/HIV co-treated children with the following modifications to their antire...
Autores principales: | Frohoff, Cordula, Moodley, Magendhree, Fairlie, Lee, Coovadia, Ashraf, Moultrie, Harry, Kuhn, Louise, Meyers, Tammy |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3044164/ https://www.ncbi.nlm.nih.gov/pubmed/21383838 http://dx.doi.org/10.1371/journal.pone.0017273 |
Ejemplares similares
-
Decreased bone turnover in HIV-infected children on antiretroviral therapy
por: Shiau, Stephanie, et al.
Publicado: (2018) -
Effect of Maternal HIV-1 Status and Antiretroviral Drugs on Haematological Profiles of South African Infants in Early Life
por: Schramm, Diana B, et al.
Publicado: (2010) -
Age at antiretroviral therapy initiation and cell-associated HIV-1 DNA levels in HIV-1-infected children
por: Kuhn, Louise, et al.
Publicado: (2018) -
Predictors of loss to follow-up among children in the first and second years of antiretroviral treatment in Johannesburg, South Africa
por: Sengayi, Mazvita, et al.
Publicado: (2013) -
Early antiretroviral treatment of infants to attain HIV remission
por: Kuhn, Louise, et al.
Publicado: (2020)